ceo thibaut mongon - Search News

Order byBest matchMost fresh

Kenvue, CEO Thibaut Mongon

Digest more

· 1d · on MSN

Kenvue CEO Mongon leaves the consumer health company as it continues its strategic review

Kenvue also said that it is continuing to work with its strategic review committee to explore options for the company.

· 1d · on MSN

Tylenol maker Kenvue ousts CEO amid board's strategic review

Cosmetics Business · 8h

Kenvue ousts CEO and launches strategic review amid struggling sales

· 1d

Kenvue CEO Mongon Stepping Down as Company Continues With Strategic Review

Kenvue says that Thibaut Mongon is stepping down as its CEO as the maker of Listerine and Band-Aid brands continues with a strategic review of the company.

· 1d

Stocks to Watch Monday: Kenvue, Tesla, Synopsys, Robinhood

· 1d

Kenvue Seeks Its Own Band-Aid With CEO Departure and Strategic Review. The Stock Rises.

· 9h

Kenvue: New CEO, Watch The Dividend (Rating Downgrade)

High debt load and rising rates strain Kenvue’s free cash flow and dividend sustainability.

SchaeffersResearch.com · 1d

Call Traders Circle Tylenol Parent Amid C-Suite Swap

· 1d

Kenvue appoints Kirk Perry as interim CEO, sees Q2 adjusted EPS of $0.28 to $0.29

1don MSN

Tylenol parent Kenvue has a new CEO, and he has lots of work to do to mollify activist investors

All that culminated on Monday with the abrupt resignation of Kenvue CEO Thibaut Mongon, his replacement by board director Kirk Perry on an interim basis, and the confirmation that Kenvue is undertaking a strategic review in the hopes of “optimizing” a sprawling portfolio and boosting profitability.

Stocktwits on MSN1d

Kenvue CEO Thibaut Mongon Steps Down, Director Kirk Perry To Take On Interim CEO Role

Kenvue (KVUE) said on Monday that CEO Thibaut Mongon has left the company and stepped down from its board, with Kirk Perry succeeding him as the interim chief executive officer, effective immediately.

Renuncia CEO de Kenvue mientras la empresa sigue con su revisión estratégica

Por MICHELLE CHAPMANEl CEO de Kenvue dejará su cargo mientras el fabricante de las marcas Listerine y Band-Aid continúa con una revisión estratégica de sus negocios. Thibaut